$莱斯康制药(LXRX)$ 8-K - Current report Filed: 2018-04-23 AccNo: 0001062822-18-000015 Size: 200 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接